More than three dozen attorneys general are urging the FDA to take “decisive action” against counterfeit obesity drugs.
A telehealth company partnered with a pharmacy that lacked a required license, raising doubts about the safety and efficacy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback